Short answer
ACCENDRA HEALTH INC/VA/ (ACH) filed an 8-K current report with the SEC on October 30, 2026 reporting Item 3.01 (Notice of Delisting), Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). NYSE deficiency: average market capitalization below $50.0 million and stockholders’ equity below $50.0 million.
- This filing includes Item 3.01, an item that often signal trouble.
ACCENDRA HEALTH INC/VA/ 8-K event analysis
AI summary of each reported item and its exhibits
Item 3.01 · Notice of Delisting
- NYSE deficiency: average market capitalization below $50.0 million and stockholders’ equity below $50.0 million
- Common stock remains listed immediately, with no current trading suspension or delisting
- Business plan due within 45 calendar days, targeting compliance within 18 months
- NYSE quarterly monitoring possible if the plan is accepted
- Company must notify NYSE of its intent within 10 business days, increasing execution and financing pressure
Item 7.01 · Regulation FD Disclosure
- October 30, 2026 press release furnished under Regulation FD, indicating material information was publicly disclosed
- Exhibit 99.1 contains the substantive announcement and is the key document for investor review
Item EX-99.1 · Exhibit EX-99.1
- NYSE noncompliance: 30-day average market capitalization and stockholders’ equity below the $50.0 million standard
- No immediate delisting: Common Stock continues trading on NYSE during the remediation period
- Business plan due within 45 calendar days, targeting compliance within 18 months
- NYSE acceptance would trigger quarterly monitoring, creating ongoing execution and delisting risk
- Notice does not change operations or SEC reporting obligations
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other ACCENDRA HEALTH INC/VA/ 8-K filings
Get the next ACH 8-K as it lands
Follow ACH for push alerts, or ask the research agent what this filing means.